Salute e Benessere

Oxurion Receives Transparency Notifications from Atlas Special Opportunities…

Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC Leuven, BELGIUM – April 11, 2024 – 07:00 PM CETOxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation 1it has received two transparency notifications as follows: Oxurion received a first transparency notification on April 10, 2024, from Atlas Special Opportunities, LLC indicating that as of April 1,...
Nasdaq GlobeNewswire
11/04/2024

Iba – Transparency Notification

Louvain-la-Neuve, Belgium, April 11, 2024, 6pm Summary of the notificationIBA (Ion Beam Applications), the world's leading provider of proton therapy solutions for the treatment of cancer, announces that it has to issue a transparency notification, in accordance with Article 14, al. 1 of the Transparency Law of May 2, 2007, on disclosure of major holdings, further to the notification received on April 9, 2024. In its notification, Vallcara Limited indicated that following an...
Nasdaq GlobeNewswire
11/04/2024

Transparency Notifications from Shareholders

PRESS RELEASE REGULATED INFORMATION11 April 2024, 06:00 pm CEST Ghent, Belgium – 11 April 2024 – Sequana Medical NV (Euronext Brussels: SEQUA)(the " Company " or " SequanaMedical "), a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, announces today that it received transparency notifications from the shareholders listed below, notifying the number of voting rights attached to shares mentioned next to their respective names in the table…
Nasdaq GlobeNewswire
11/04/2024

Travel Accessories Market Size to Grow USD 95.7 Billion by 2031 at a CAGR of…

Get Free Sample: https://reports.valuates.com/request/sample/ALLI-Auto-0J527/Travel_Accessories_Market Get Free Sample:https://reports.valuates.com/request/sample/ALLI-Auto-0J527/Travel_Accessories_Market Major Factors Driving the Growth of Travel Accessories Market : The need for a variety of travel accessories has increased due to the rise in international travel, which is being driven by rising disposable incomes and an expanding middle class. The market has also been helped...
PR Newswire
11/04/2024

Healthcare Revolution 2024: Largest Industry Event Moves to Drive Superior…

Learn exciting strategies to get ahead in the ever-evolving medical tourism landscape and ways to optimize your corporate health systems that no one else will teach you. Self-funded employers will also learn from our speakers the effective strategies to cut healthcare and pharmaceutical costs by 50%, lower deductibles, co-insurance and copays, and ways to achieve zero-rate increases in healthcare costs. Learn exciting strategies to get ahead in the ever-evolving medical tourism landscape and...
PR Newswire
11/04/2024

Penicillin Intermediates Market Size to Grow USD 14330 Million by 2029 at a CAGR…

Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-0P13061/Global_Penicillin_Intermediates_Market Get Free Sample : https://reports.valuates.com/request/sample/QYRE-Auto-0P13061/Global_Penicillin_Intermediates_Market Major Factors Driving the Growth of Penicillin Intermediates Market Effective antibiotic treatments are becoming increasingly necessary due to the rising incidence of bacterial illnesses worldwide, which is driving the expansion of the penicillin...
PR Newswire
11/04/2024

Floor Pad Market Size to Grow USD 159 Million by 2030 at a CAGR of 6% | Valuates…

Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-4M7495/Global_Floor_Pad_Market Get Free Sample:https://reports.valuates.com/request/sample/QYRE-Auto-4M7495/Global_Floor_Pad_Market Major Factors Driving the Growth of Floor Pad Market The market for floor pads is expected to grow due to a number of factors, including the growing need for efficient floor maintenance solutions from the commercial sector, technological advancements that improve product...
PR Newswire
11/04/2024

Fill Finish Manufacturing Market Worth $25.7 billion | MarketsandMarkets™

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=6249609 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=6249609 Browse in-depth TOC on "Fill Finish Manufacturing Market" 495 - Tables 50 - Figures 440 - Pages Fill Finish Manufacturing Market Scope: Consumables segment had the largest estimated share of the fill finish manufacturing market. Based on product, the fill finish...
PR Newswire
11/04/2024

New Zealand Power Tool Market to Reach US$ 286.1 Million by 2031, Rising at a…

The New Zealand Power Tool Market is being primarily driven by the increasing demand for DIY home improvement projects. With the growing trend of homeowners taking on renovation and construction projects themselves, the demand for power tools is on the rise. Additionally, the flourishing construction industry in New Zealand is also fueling the market growth, as power tools are essential for various construction activities. The New Zealand Power Tool Market is being primarily driven by the...
PR Newswire
11/04/2024

U.K. Luxury Bedding Market Size to Surpass Around US$ 132.9 Million 2031…

The U.K. Luxury Bedding Market is driven by the increasing demand for premium quality bedding among consumers. As people are becoming more aware of the importance of quality sleep for overall health and well-being, they are willing to invest in luxurious bedding products that offer comfort, durability, and style. Additionally, the growing trend of home décor and interior design is also fueling the demand for luxury bedding in the U.K. The U.K. Luxury Bedding Market is driven by the increasing...
PR Newswire
11/04/2024

Biotech Innovations Paving the Way in Breast Cancer Fight

Coming off of a late-2022 FDAFast Track Designation of Oncolytics Biotech Inc.'s (NASDAQ:ONCY) (TSX:ONC) flagship asset pelareorep for the treatment of pancreatic cancer, momentum is building towards another important FDA milestone, this time for breast cancer. Oncolytics recently announced the submission of a Type C meeting request to the FDA to discuss its new planned trial for pelareorep in treating HR+/HER2- metastatic breast cancer (mBC). Coming off of a late-2022FDAFast Track...
PR Newswire
11/04/2024

Qinecsa Host Industry Discussion on Mastering Medical Device Regulations to…

Industry expert, Veronika Valdova, will guide participants through key regulatory requirements, integration challenges, and actionable steps for building resilient processes to support combined drug and device portfolios within primarily pharma-focused organizations. Industry expert, Veronika Valdova, will guide participants through key regulatory requirements, integration challenges, and actionable steps for building resilient processes to support combined drug and device portfolios within...
PR Newswire
11/04/2024

BioSenic and its restructuring practitioner (Me Yves Brulard) submit a global…

PRESS RELEASE - PRIVILEGED INFORMATIONA final circular of the creditors on the basis of XX 83/23 of the Economic Law Code (ELC) will take place before the Court grants authorisation, in accordance with article XX 83/26 of the ELC, to submit the plan to the vote of each class of creditors and to homologation. The creditors will be aware of the plan, which by law contains information that could be privileged. Mont-Saint-Guibert, Belgium, 11 April 2024, 14:00 CET –BioSenic...
Nasdaq GlobeNewswire
11/04/2024

According to a Purina poll, nearly half of dog owners have made at least one new…

Martina Mchowat, web lead for Purina.co.uk, where owners can find huge amounts of advice, tips and expertise on all elements of finding and caring for their furry companions, said: "It's well known that walking a dog regularly is great for getting people moving and active as well as creating routines and spending more time in the fresh air. But one of the lesser-known positive impacts of walking a dog is the increased social interaction many people experience. Martina Mchowat, web lead for…
PR Newswire
11/04/2024

Tiziana Life Sciences Announces Platform Presentation of New Quantitative PET…

TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough neuro-immunomodulation therapies, today announced an upcoming oral presentation, titled, “Treatment of PIRA with Nasal Foralumab Dampens Microglial Activation and Stabilizes Clinical Progression in Non-Active Secondary Progressive MS” that will be presented during the “Multiple Sclerosis: Therapeutics and Clinical Decision Making” session at the Annual Meeting of the American Academy of Neurology, to be...
Nasdaq GlobeNewswire
11/04/2024

Oncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep…

SAN DIEGO and CALGARY, AB, April 11, 2024 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapeutics for oncology, is pleased to announce the submission of a Type C meeting request to the FDA. This meeting aims to discuss the Company's planned registration-enabling trial for pelareorep in HR+/HER2- metastatic breast cancer (mBC). SAN DIEGOandCALGARY, AB , April 11, 2024 /PRNewswire/ -- Oncolytics Biotech ®Inc...
PR Newswire
11/04/2024

Pharmaceutical Innovation Drives Steady 8.70% CAGR for Injectable Drug Delivery…

The market has witnessed steady growth due to this trend, with a projected CAGR of 8.70% through 2034. Pharmaceutical companies operating in the medical industry are capitalizing on the opportunity to create more efficient devices for treating chronic and age-related conditions. The market has witnessed steady growth due to this trend, with a projected CAGR of 8.70% through 2034. Pharmaceutical companies operating in the medical industry are capitalizing on the opportunity to create more...
PR Newswire
11/04/2024

Good results Van Leeuwen Pipe and Tube Group despite less favorable market…

Total sales from stock was lower in all markets than the previous year due to decreased market demand. This was, however, offset by a higher volume in direct deliveries and projects. This led to virtually the same total net sales as in 2022, despite a difficult market. Van Leeuwen maintained its market share in the European industrial markets. Demand was lower in the construction and mechanical engineering market segments, but in the hydraulics and automotive market segments demand was good. Van…
PR Newswire
11/04/2024

Novartis tender offer for MorphoSys AG commences

Basel, April 11, 2024– Novartis published today the offer document for the voluntary public takeover offer by its wholly owned subsidiary Novartis BidCo AG for all outstanding shares of MorphoSys AG (“MorphoSys”), including all shares represented by MorphoSys American Depositary Shares (the “Offer”), for an offer price of EUR 68.00 per share in cash. The offer price corresponds to a premium of 142% on the volume-weighted average price during the last three months, as of the unaffected...
Nasdaq GlobeNewswire
11/04/2024

Don't Miss Out - Join the 7th IFPA Conference: Uncovering the Broad Spectrum of…

We are honored to have April Armstrong, Chair of the Scientific Executive Committee (SEC), as the President of the 7th IFPA Conference. We are honored to have April Armstrong , Chair of the Scientific Executive Committee (SEC), as the President of the 7th IFPA Conference. Esteemed experts includingDr.Adam Reich ,Dr.Lihi Eder ,Dr.Wiebke Sondermann ,Dr.Ennio Lubrano ,Dr.Bruce Strober , andDr.Laura Coates will share their insights on various topics such as...
PR Newswire
11/04/2024

Orion publishes Interim Report for January–March 2024 and holds a webcast on 25…

ORION CORPORATIONPRESS RELEASE11 APRIL 2024 at 9.30 EEST Orion publishes Interim Report for January–March 2024 and holds a webcast on 25 April 2024 Orion will publish Interim Report for January–March 2024 on Thursday, 25 April 2024 at approximately 12.00 noon EEST. The release and related presentation material will be available on the company's website at www.orion.fi/en/investors after publishing. Webcast and conference call A webcast and a conference call for analysts,...
Nasdaq GlobeNewswire
11/04/2024

ONWARD® Medical Announces Publication of Full Year 2023 Financial Results and…

The webcast will be held on April 25, 2024, at 2:00PM CET / 08:00AM ET. It will be hosted by CEO Dave Marver and Interim CFO Khaled Bahi, who will discuss highlights from 2023 and provide a business update.To join the webcast via Zoom, please register usingthis link.Participants may also join by phone:+32 2 290 9360 (Belgium)+49 69 3807 9884 (Germany)+31 20 794 0854 (Netherlands)+41 22 591 0156 (Switzerland)+44 203 481 5240 (United Kingdom)+1 346 248 7799 (US) ...
Nasdaq GlobeNewswire
11/04/2024

Idorsia takes steps to address short-term liquidity needs

Ad hoc announcement pursuant to Art. 53 LR A bondholders meeting is expected to take place on April 30, 2024, to request the right to repay the bonds maturing in 2024, fully or partially in shares of IdorsiaMain investors Jean-Paul and Martine Clozel fully support this requestFinancial status as of March 31, 2024, to be published on April 17, 2024, in conjunction with the invitation to the bondholder meetingPostponement of the Full Year 2023 and Q1 2024 Financial Results publication to...
Nasdaq GlobeNewswire
11/04/2024

Record revenue of €209 million in first quarter reflecting 15% topline growth

Regulated information - inside information Nazareth (Belgium)/Rotterdam (The Netherlands), 11 April 2024 – 7:00 AM CET Record revenue of €209 million in first quarter reflecting 15% topline growthFagron, the leading global player in pharmaceutical compounding today publishes its quarterly results for the period ending 31 March 2024. Key Highlights Revenue growth accelerated to 15.3% reported growth (14.9% at CER) resulting in €209.2 million, supported by all regionsOrganic...
Nasdaq GlobeNewswire
11/04/2024
Altri  Comunicati